Former MOH Secretary General Dato' Seri Dr Chen Chaw Min takes over effective 15 July 2022
Group to collaborate with United Doctors Hospital for genetic screening tests and cell therapies
The new placement shares will rank equally in all respects with existing Malaysian Genomics shares except they will not be entitled to any dividends, rights, allotments
Genomics is collaborating with Rinani Genotec to develop and offer genetic screening tests catering to athletes and those with active lifestyles
This followed the decision by Bursa Securities Malaysia Bhd to grant the Group a waiver in submitting a regularisation plan after being classified as an affected listed corporation pursuant to Rule 8.03A of the Listing Requirements.